After being diagnosed with a rare and deadly form of malignant melanoma - acral lentiginous melanoma - Dr George McGavin embarks on a highly emotional and deeply personal journey as he goes through treatment for his cancer. George’s treatment is targeted drug therapy, using drugs approved for use by the NHS only weeks before his diagnosis. During this journey, he is given unprecedented access to the process and science behind his medical treatment and diagnosis. He also meets some of the most highly regarded scientists in the field of cancer research in his quest to understand not just his disease but what the future holds as a whole for cancer treatment. Amongst them are Professor Sir Michael Stratton, director of the Wellcome Sanger Institute and chief executive officer of the Wellcome Genome Campus, whose work resulted in the discovery of the mutation in the B RAF gene responsible for his form of melanoma. George also travels to Houston, Texas to meet Professor James P Allison, winner of the 2018 Nobel Prize in Medicine, to find out about his pioneering work in the field of immunotherapy - the greatest breakthrough in cancer research in a century. Back home in his own hospital, he meets a unique group of stage four melanoma patients who owe their lives to Professor Allison’s work. Ultimately, his journey culminates when he receives his prognosis, after three months of treatment, which will determine his future. Will these groundbreaking drugs actually work?
Gloria Hunniford and Chris Bavin unravel the truth behind food stories that have dominated the front pages. In this episode, they discover how it's not just what you eat that can make a difference to how you feel, but when you have it and how you cook it. The truth behind the headlines about the dangers of cooking with olive oil, and barbecues, is revealed. Several long-established beliefs are put to the test, with experiments to see whether three meals a day is the most effective way to fuel your body, and if breakfast really is the most important meal of the day.
Not all the microbes that live on us or inside us are benign, and it is only thanks to the superhuman nature of our bodies that we survive constant attack. However, humans are becoming increasingly vulnerable to disease. This programme examines the dramatic increase in allergic diseases such as asthma, eczema and hayfever.
Coined medicine for the soul by LSD inventor Albert Hoffman, this drug is back in the spotlights. After the widespread use in the 60’s where young kids tried to free their minds by going on psychedelic adventures and the banning of the drug that followed, any scientific research was halted. Yet, LSD was the raft that took people to the brink of enlightenment, madness, life-lasting wonderment and revolutionary insights into reality. This short unbiased documentary gives us a quick history of the use and banning of LSD and the potential it still holds today. Can it be used as a smart drug? Can it cure mental illnesses?
In the early days of the space race, agency researchers in Russia and at NASA really weren't sure all what would happen to an astronaut in space. They didn't know if a human mind could handle actually seeing Earth or what would happen to the human body when exposed to long periods of weightlessness. Would their blood forget which way to pump? Would their eyeballs shift or their inner ears wig out? They sent up mice and monkeys and dogs, to see what happened, and in 1961, the Russians strapped a man to a rocket headed for orbit. Yuri Gagarin was the first person in space. The ultimate human guinea pig, he survived, becoming an international hero.
Hear firsthand from individuals struggling with addiction and follow the cutting-edge work of doctors and scientists as they investigate why addiction is not a moral failing, but a chronic, treatable medical condition. Easy access to drugs like heroin, fentanyl, and even prescription medications like OxyContin has fueled an epidemic of addiction - the deadliest in US history. Now, science is revealing how addiction affects the brain, and top experts are gathering evidence about how we should address our drug problem, from embracing evidence-based treatments, to rethinking public policies.